CR20110555A - ANTI-FGFR3 ANTIBODIES AND METHODS THAT USE THEM - Google Patents

ANTI-FGFR3 ANTIBODIES AND METHODS THAT USE THEM

Info

Publication number
CR20110555A
CR20110555A CR20110555A CR20110555A CR20110555A CR 20110555 A CR20110555 A CR 20110555A CR 20110555 A CR20110555 A CR 20110555A CR 20110555 A CR20110555 A CR 20110555A CR 20110555 A CR20110555 A CR 20110555A
Authority
CR
Costa Rica
Prior art keywords
methods
fgfr3 antibodies
antibodies
fgfr3
compositions
Prior art date
Application number
CR20110555A
Other languages
Spanish (es)
Inventor
Ashkenazi Avi
Qing Jing
Wiesmann Christian
Wu Yan
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of CR20110555A publication Critical patent/CR20110555A/en

Links

Abstract

La invención presenta anticuerpos de FGFR3 y composiciones que los comprenden y métodos para usar estos anticuerpos.The invention features FGFR3 antibodies and compositions comprising them and methods for using these antibodies.

CR20110555A 2009-03-25 2011-10-20 ANTI-FGFR3 ANTIBODIES AND METHODS THAT USE THEM CR20110555A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13622209P 2009-03-25 2009-03-25

Publications (1)

Publication Number Publication Date
CR20110555A true CR20110555A (en) 2012-01-06

Family

ID=48407314

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20110555A CR20110555A (en) 2009-03-25 2011-10-20 ANTI-FGFR3 ANTIBODIES AND METHODS THAT USE THEM

Country Status (1)

Country Link
CR (1) CR20110555A (en)

Similar Documents

Publication Publication Date Title
CO6450665A2 (en) ANTI-FGFR3 ANTIBODIES AND METHODS THAT USE THEM
CR20150088A (en) ANTI-NOTCH1 NRR ANTIBODIES
CL2017000590A1 (en) Anti-cll-1 and immunoconjugate antibodies
CR20160206A (en) Compositions and methods for antibodies that target C5 complement protein
CL2015002742A1 (en) Binding molecules for bcma and cd3.
CR20140529A (en) ANTIBODIES AND IMMUNOCATE PLAYS AGAINST LY6E AND METHODS OF USE
CR20150049A (en) ANTI-CD79B ANTIBODIES AND IMMUNOCATION
CY1118250T1 (en) CERTAIN TRIAZOLOPYRAZINS, THEIR COMPOSITIONS AND METHODS FOR USE
ECSP099027A (en) ANTI-DLL4 ANTIBODIES AND METHODS THAT USE THEM
CO7151527A2 (en) Anti-CD79 B and Immunoconjugate Antibodies
CR20150247A (en) ANTIHEMAGLUTININE ANTIBODIES AND METHODS OF USE
ECSP13012784A (en) ANTI-MESOTHELINE AND IMMUNOCONJUGATED ANTIBODIES
CR20140441A (en) ANTI-LGR5 AND IMMUNOCATE PLAYERS
CR20150048A (en) ANTI-CD22 ANTIBODIES AND IMMUNOCADES
UY34736A (en) ? INDOL AND INDAZOL COMPOUNDS THAT ACTIVATE AMPK ?.
CR20150047A (en) ANTI-CD22 ANTIBODIES AND IMMUNOCATE PLAYERS
BRPI0813981A2 (en) synthetic agonists of tlr9.
CR20140212A (en) ANTI-HTRA1 ANTIBODIES AND METHODS OF USE
UY3725Q (en) FOOD CONTAINER
ECSP11011344A (en) NEW ANTIBODIES ANTI-? 5? 1 AND ITS USES
ECSP088743A (en) ANTIBODIES FOR EGFL7 AND METHODS FOR USE
HN2009000566A (en) NEW DERIVATIVES OF DIOSMETINE, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT.
ECSP13012679A (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE ALISPORIVIR
EA201300514A1 (en) DECOMPOSABLE FIBERS
CR20110555A (en) ANTI-FGFR3 ANTIBODIES AND METHODS THAT USE THEM